Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial

Completed · Phase 1/Phase 2

Conditions studied: Post-Traumatic Stress Disorders

In brief

The purpose of this study is to determine whether the administration of risperidone is effective in the treatment of selective serotonin reuptake inhibitor (SSRI)-resistant post-traumatic stress disorder (PTSD) in civilians.

Key facts

Study ID

NCT00133822

Run by

Emory University

People needed

65

Starts

2004-04-01

Expected to finish

2006-09-01

Last updated by the study team

2015-08-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Meets criteria for DSM-IV PTSD for a minimum of one month duration
• Clinician-Administered PTSD Scale (CAPS) score > or = to 50
• Able to read and complete questionnaires and interviews
• Negative urine drug screen

You may not qualify if…

• Pregnant or nursing
• Primary psychotic disorder; psychotic disorder; or cognitive disorder.
• Prominent suicidal or homicidal ideation
• Alcohol or substance dependence within 3 months of starting study
• Primary anxiety disorder or bipolar disorder
• Patients currently being treated with antipsychotic medication
• Patients in active psychotherapy aimed at PTSD
• Combat-related PTSD

Where it is running

• Emory University School of Medicine — Atlanta, Georgia, United States
• Duke University Medical Center South — Durham, North Carolina, United States
• Medical University of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.